Locations:
Search IconSearch

Cerebrovascular

22-NEU-3366031-CQD-Hero-650×450

Flow Diversion for Ruptured Intracranial Mycotic Aneurysms Initially Treated With Coil Embolization

Case series demonstrates successful retreatment of this rare emergency

23-NEU-3605958-acute-stroke-therapy-650×450

Timing in Acute Stroke Management: Two Analyses Offer Nuanced Insights for Further Study

Retrospective looks at a “direct to angio” MSU strategy and mechanical thrombectomy beyond 24 hours

23-NEU-3600027-CQD-Hero-650×450

Collaboration Between Acute Care and Rehab Hospitals Drives Down Readmissions in Stroke Patients

Cleveland Clinic’s approach to improve care transitions and patient safety

Medications in the ICU. Medicinal lines next to patient bed
December 5, 2022/Digestive

Researchers Advance Novel Studies of Hidden Brain Threats in Acute Liver Failure

Multidisciplinary efforts to refine cerebral hemodynamic goals in a high-risk population

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Pharmacist at work
November 25, 2022/Neurosciences/Cerebrovascular

Study Underscores Need to Optimize Pharmacotherapy After Neuro ICU Discharge

Medication-focused intervention key to management success in a challenging population

22-NEU-2763209-CQD-Hero-650×450

Closing Racial Gaps in Cerebrovascular Mortality

Minority Stroke Program addresses racial disparities pinpointed in a recent study

22-NEU-2763210-CQD-Hero-650×450
March 21, 2022/COVID-19

Cerebrovascular Injury From ARDS: Is It More Common in the Setting of COVID-19?

Comparative MRI study suggests unique pathophysiology in COVID-19 context

22-NEU-2646461-thrombolysis-ischemic-stroke-650×450

Making the Switch From Alteplase to Tenecteplase for Acute Ischemic Stroke

Advice on why and how based on Cleveland Clinic’s recent enterprise-wide transition

21-NEU-2429063-CQD-Hero-650×450

DBS for Post-Stroke Rehab: Encouraging Phase I Results Pave Way for Controlled Study

First-in-man trial demonstrates safety, promising functional response rates

21-NEU-2258158 IV-tPA-for-ELVO-stroke_650x450
September 8, 2021/Neurosciences/Cerebrovascular

In ELVO Strokes, Giving IV tPA Within the ‘Golden Hour’ Makes It Much More Effective

Retrospective study finds benefits of ultra-early therapy extend to this understudied subgroup

BackPage 3 of 4Next

Advertisement

Ad